In this study, Bifidobacterium animals subsp. lactis KLDS 2.0603 which has high survival rate and adhesion ability after simulated GIT treatments was selected as a model strain
Select colonies demonstrating reduced gepotidacin susceptibility underwent whole genome sequencing and comparative genomics to identify potential mechanisms of resistance. Resistant mutants and their
